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Problem Identification
• Several diabetic patients are reluctant to take the extra step 
in their long-term health care, particularly problematic as it 
relates to cardiovascular disease.
• In addition to difficulty controlling blood glucose levels, 
several patients struggle maintaining an appropriate blood 
pressure. This is often due to a reluctance to maintain a 
proper diet, exercise regularly, and take certain 
medications. 
• Studies have shown that compliance with exercise 
regimens falls from 80% at 6 weeks to 20% at one year. 
• Many patients reluctant to start on a statin, and some 
physicians even hesitant to adhere to the new 
recommendations proposed by the AHA. 
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Description of Need
• Because these other aspects of long term health oft go neglected, 
patients are at increased risk for vascular disease and resultant 
complications, including coronary heart disease. 
• Often these patients are in for 15 minute follow-up visits, and much 
of the time present with other complaints. There is simply not 
enough time during the visit to address all the preventive measures 
and medications patients should be taking. More importantly, there 
isn’t enough time to address their increased risk and explain why 
these measures and medications are important and beneficial. 
• This project aims to create a tool that will address these issues, and 
advise patients on what they should be doing and why. It will be 
geared toward improving vascular health, and especially on 
supporting the new statin guideline for diabetics. 
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Monetary Implications
• In the US, the lifetime cost for diabetes care is 
estimated to be between $56,000 and $125,000 
dollars per patient, depending on when a patient 
is diagnosed. This amounts to several billions of 
dollars per year spend on US diabetic patient 
care. 
• Diabetic complications account for 48%-64% of 
these lifetime costs. 57% of those costs can be 




• I spoke with all 5 physicians at the practice, who thought 
this would be very helpful, reiterating that it is difficult to 
address patient complaints and give adequate teaching on 
diabetic health maintenance. 
• They also reported many patients who are reluctant to take 
certain medications, such as statins, because they do not 
understand the benefits (especially long-term).
• I also spoke with registered nurse Name Withheld, who 
heads the community health efforts at BFH. He also 
stressed the importance of diabetes care, pointing out that 
at least over 30% of the patient population at BFH have a 
diagnosis of Diabetes Mellitus. He believed that a tool for 
patients to take home, such as this brochure, would be an 
excellent option to improve diabetes health management.
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Intervention and Methodology
• Developed a brochure to be used as an 
educational tool for diabetes patients, 
especially with regard to cardiovascular health.
• Included the following core concepts from the 





• Cues to Action
• Self -Efficacy
Results/Response
• Physicians at the practice were very pleased with the product, and 
put it into use same day it became available.
• Immediately was evident this saved time during the encounter, and 
provided patients the opportunity to take home readily available 
information to contemplate as they create and adjust action plans 
for their health management.
• Patients were very receptive to brochure, and found the checklist 
very useful. 
• Future projects can assess quantitatively how helpful patients found 
the brochure, how helpful physicians found the brochure, and 
where or not a difference was made because of the brochure. This 
can be measured by actual improvement in health goals (BP, A1c, 
etc.) or with patient’s assessment of general helpfulness in 
maintaining healthy habits.
Effectiveness and Limitations
+ Convenient for physicians to pass along to patients (especially during 
shorter encounters, i.e. follow-up appointments).
+ Encourages patients to be actively involved in their medical care (ACA)
+ Brochures serve as effective tools  in promoting patient-physician dialogue 
in high risk populations. 
+ Addresses a variety of diabetes patient needs
+ Brochures provide a source of repetitive material to enforce health 
concepts and needs of diabetics
-Linguistically appropriate health information (literacy level of brochure)
-Intervention does not stand alone, must also include face to face 
communication with patient.
- Not tested on patients and developed without patient feedback
Recommendations for future projects
• Use this brochure in addition to face to face 
interaction with patient. 
• Future projects should test the effectiveness of 
this brochure increasing health literacy of 
diabetes patients, as well as implementation of 
recommended treatments and prevention 
strategies. Assessment of patients achieving 
goals, such as target A1c, BP, etc. can also be 
performed. 
• Future brochures should focus on the issues that 
both patients and physicians think are important.
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